Search - tctmd.com

Displaying 61 - 80 of 802

Sort: Relevancy | Date

Presentation TCT 2016

CT for Automated Quantification of Coronary Artery Stenosis

Presenter: Jeroen J. Bax, Jonathon A. Leipsic, James K. Min, Paul Knaapen

November 01, 2016

Presentation TCT 2016

ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After Coronary Artery Stent Implantation

Presenter: Howard C. Herrmann, Robert J. de Winter, Hiroki Shiomi

November 01, 2016

Presentation TCT 2016

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Presenter: Sripal Bangalore, George D. Dangas, Philippe Généreux

November 01, 2016

Presentation TCT 2016

Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study

Presenter: Fernando Alfonso, Ran Kornowski, Jelmer Westra

November 01, 2016

News Industry News

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

November 01, 2016

News Conference News TCT 2016

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Yael L. Maxwell

November 01, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

Using Intravascular Imaging and Physiology to Guide CHIP Cases: The Essentials

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gary S. Mintz

October 31, 2016

Presentation TCT 2016

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nick Curzen

October 31, 2016

Presentation TCT 2016

Post-PCI FFR Measurements: Lessons From FAME I and II

Presenter: Allen Jeremias, Nico H.J. Pijls, Zsolt Piroth

October 31, 2016

Presentation TCT 2016

Contrast as a Hyperemic Agent: Easier, but Sufficient?

Presenter: Allen Jeremias, Nico H.J. Pijls, Nils Johnson

October 31, 2016

Presentation TCT 2016

FFR and CFR: Similarities, Differences, and When to Prefer Each

Presenter: Allen Jeremias, Nico H.J. Pijls, Tim P. van de Hoef

October 31, 2016

Presentation TCT 2016

TCT 96: Progression of Coronary Atherosclerosis Despite Lipid-Lowering Therapy in Diabetic Patients Compared to Non-Diabetic Ones. Study With 3D Intravascular Ultrasound and Virtual Histology

Presenter: Farouc Jaffer, Amir Lerman, Tomas Kovarnik

October 31, 2016

Presentation TCT 2016

TCT 76: Temporal Change of In-Stent Thrombus Immediately After Percutaneous Coronary Intervention Within Five Minutes Using Optical Coherence Tomography

Presenter: Hector M. Garcia-Garcia, Ik-Kyung Jang, Hyuck Jun Yoon

October 31, 2016

Presentation TCT 2016

TCT 95: The Interplay Between Features of Plaque Vulnerability and Hemodynamic Relevance of Coronary Artery Stenoses

Presenter: Farouc Jaffer, Amir Lerman, Sabahattin Umman

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

Presentation TCT 2016

TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study

Presenter: Farouc Jaffer, Amir Lerman, Elvin Kedhi

October 31, 2016

Presentation TCT 2016

TCT 93: Near-Infrared Spectroscopy-Derived Lipid Core Burden Index Predicts Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease During 4.3 Year Follow-up

Presenter: Farouc Jaffer, Amir Lerman, Eric Boersma

October 31, 2016

Presentation TCT 2016

TCT 32: Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and Four-Year Clinical and Imaging Results

Presenter: Jacques J. Koolen, Yoshinobu Onuma, Alexandre Abizaid

October 31, 2016

Presentation TCT 2016

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu

October 31, 2016

Advertisement

CT for Automated Quantification of Coronary Artery Stenosis

ReACT: A Prospective, Randomized Trial of Routine Angiographic Follow-up After Coronary Artery Stent Implantation

Lesion Optimization Before PCI: Role of Imaging/Atherectomy

Physiological Testing of Coronary Artery Stenosis by Computation of Invasive Coronary Angiography. The Wire-Free Functional Imaging (WIFI-II) Study

Sudy Indicates PCI Of NIRS-Defined Lipid-Rich Plaque Is Safe And Not Associated With A Greater Incidence Of Adverse Outcomes Compared To PCI of Non Lipid-Rich Plaque

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Using Intravascular Imaging and Physiology to Guide CHIP Cases: The Essentials

Routine FFR at the Time of Diagnostic Angiography - Ready for Primetime?

Post-PCI FFR Measurements: Lessons From FAME I and II

Contrast as a Hyperemic Agent: Easier, but Sufficient?

FFR and CFR: Similarities, Differences, and When to Prefer Each

TCT 96: Progression of Coronary Atherosclerosis Despite Lipid-Lowering Therapy in Diabetic Patients Compared to Non-Diabetic Ones. Study With 3D Intravascular Ultrasound and Virtual Histology

TCT 76: Temporal Change of In-Stent Thrombus Immediately After Percutaneous Coronary Intervention Within Five Minutes Using Optical Coherence Tomography

TCT 95: The Interplay Between Features of Plaque Vulnerability and Hemodynamic Relevance of Coronary Artery Stenoses

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

TCT 94: Impact of Thin-Cap Fibroatheromas on Unanticipated Ischemic Events in Medically Treated Patients With Diabetes Mellitus: Insights From the PROSPECT Study

TCT 93: Near-Infrared Spectroscopy-Derived Lipid Core Burden Index Predicts Major Adverse Cardiovascular Events in Patients With Coronary Artery Disease During 4.3 Year Follow-up

TCT 32: Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and Four-Year Clinical and Imaging Results

FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content